Called RxPass, the service lets patients order generic medications that treat more than 80 common health conditions.
prescription drugs
Posted inHealth, Nation & World, News
FDA panel backs removal of unproven pregnancy drug
Some panelists encourage drug company Covis to continue studying the drug to determine if a subgroup of women could benefit.
advertisement
Posted inNation & World, News
Biden pushing lower prescription drug costs in midterm press
The White House said President Biden will sign an executive order that will direct the U.S. Department of Health and Human Services to look for additional ways to lower drug costs.
Posted inBusiness, Nation & World, News
Biden pushing lower prescription drug costs in midterm press
President Joe Biden will head to a community college in Irvine, California, on Friday to meet with older Americans and tout his administration’s efforts to reduce inflation and drive down costs.
Posted inOp-eds, Opinion
Commentary: Older Mainers paved way for Inflation Reduction Act’s health care savings
While we’re celebrating the law’s achievements, let’s remember the invaluable activism of one group of outspoken Mainers.
Posted inLocal & State, Politics
Insulin price cap championed by Collins stripped from spending bill by fellow Republicans
Sens. Susan Collins and Angus King both have sought to cap the drug’s price, which has shot up tenfold in the U.S. – but not other countries – in 20 years.
Posted inCops & Courts, Local & State, New England, News
Federal task force to crack down on overprescription of opioids in the region
Four additional federal prosecutors will help local and federal law enforcement bring criminal cases against doctors and medical providers who are diverting opiates for profit.
Posted inMaine Voices, Op-eds, Opinion
Maine Voices: Older Mainers deserve relief from high prescription drug costs
Congress has the power to get to the very heart of the problem – out-of-control drug prices – and right this wrong.
Posted inOp-eds, Opinion
Commentary: Medicare is cleaning up FDA’s mess on Biogen’s Alzheimer’s drug
By clarifying what evidence it needs before it will pay for medicines like Aduhelm, the agency paved the way for improved drug innovation.
Posted inMaine Voices, Op-eds, Opinion
Maine Voices: Unfair copay tactic allows health insurers to double-dip
L.D. 1783 will ensure that all Maine patients can afford their lifesaving medications.